Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Infervision Raises $18 Million to Develop Automated Scan Readers

publication date: Sep 21, 2017

Infervision, a Beijing AI/deep learning company, closed an $18 million B round to advance its automated medical diagnosis products. Founded in 2016, Infervision is developing products that read tomography and X-ray scans to diagnose cancer. The company says its products do not replace radiologists, but help them become more productive. Using Infervision technology, a doctor's time-per-scan could be reduced from ten minutes to five seconds, the company said. Qiming Venture Partners led the B round, joined by Sequoia Capital China and Genesis Capital.More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here